American Assets Investment Management’s Takeda Pharmaceutical TAK Stock Holding History

American Assets Investment Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-57,000	Closed	-$811K	–	162
2024 Q3	$811K	Hold	57,000	–	–	0.07%	150
2024 Q2	$738K	Hold	57,000	–	–	0.07%	148
2024 Q1	$792K	Hold	57,000	–	–	0.08%	143
2023 Q4	$813K	Hold	57,000	–	–	0.08%	141
2023 Q3	$882K	Hold	57,000	–	–	0.1%	138
2023 Q2	$895K	Hold	57,000	–	–	0.1%	136
2023 Q1	$939K	Hold	57,000	–	–	0.11%	134
2022 Q4	$889K	Hold	57,000	–	–	0.1%	130
2022 Q3	$739K	Hold	57,000	–	–	0.1%	135
2022 Q2	$800K	Hold	57,000	–	–	0.1%	134
2022 Q1	$816K	Hold	57,000	–	–	0.09%	145
2021 Q4	$777K	Hold	57,000	–	–	0.08%	143
2021 Q3	$934K	Hold	57,000	–	–	0.12%	132
2021 Q2	$959K	Hold	57,000	–	–	0.13%	119
2021 Q1	$1.04M	Hold	57,000	–	–	0.14%	120
2020 Q4	$1.04M	Hold	57,000	–	–	0.17%	113
2020 Q3	$1.02M	Hold	57,000	–	–	0.21%	103
2020 Q2	$1.02M	Sell	57,000 -18,510	-25%	-$332K	0.23%	100
2020 Q1	$1.15M	Hold	75,510	–	–	0.25%	103
2019 Q4	$1.49M	Hold	75,510	–	–	0.22%	110
2019 Q3	$1.3M	Hold	75,510	–	–	0.21%	116
2019 Q2	$1.34M	Hold	75,510	–	–	0.21%	116
2019 Q1	$1.56M	Buy	+75,510	New	+$1.52M	0.25%	105

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

American Assets Investment Management's TAK Position: Q4 2024 in Review

American Assets Investment Management sold out of Takeda Pharmaceutical (TAK) in Q4 2024, closing a stake of 57,000 shares — an estimated $811K sold.

American Assets Investment Management first reported a position in TAK in Q1 2019 and held it in 23 quarters. The position peaked at $1.56M in Q1 2019. 300 funds tracked by Wall St. Rank hold TAK as of Q4 2024.

American Assets Investment Management reported no remaining Takeda Pharmaceutical position as of Q4 2024 after selling out during the quarter.
American Assets Investment Management sold 57,000 Takeda Pharmaceutical shares in Q4 2024, an estimated $811K.
American Assets Investment Management first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 23 quarters.
American Assets Investment Management's Takeda Pharmaceutical position peaked at $1.56M in Q1 2019.
300 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2024.

Based on American Assets Investment Management's 13F filing for Q4 2024, filed 10 Feb 2025.